Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog

BACKGROUND: Cimicoxib is a new coxib anti-inflammatory drug for use in the dog. To determine a preclinical dosage regimen for cimicoxib in dog, a reversible model of kaolin–induced paw inflammation was used. Dosage regimens were established using pharmacokinetic/pharmacodynamic (PK/PD) modeling appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeunesse, Elisabeth C, Schneider, Marc, Woehrle, Frederique, Faucher, Mathieu, Lefebvre, Herve P, Toutain, Pierre-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892053/
https://www.ncbi.nlm.nih.gov/pubmed/24330630
http://dx.doi.org/10.1186/1746-6148-9-250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892053/
https://www.ncbi.nlm.nih.gov/pubmed/24330630
http://dx.doi.org/10.1186/1746-6148-9-250

Ejemplares similares